
An FDA advisory panel recently recommended approval of the Galleri blood test that uses DNA technology to look for evidence of over 50 cancers in people without symptoms. The idea, like all “screening” tests, is to find cancers before they cause symptoms and when they are easier to treat. While it has not […] Read more »








